Sonia Garcia

Maybe a doctor wrote "dual diagnosis" in a discharge summary, and a treatment program's website says "co-occurring disorders." You're left wondering whether your family member has one condition, two, or something different from what you thought. Here's the short answer to the dual diagnosis vs co-occurring disorders question: they describe the same situation. Both terms mean a person has a mental health condition and a substance use disorder at the same time. The difference is in the wording, not the illness.

Dual diagnosis vs co-occurring disorders: what each term means

Co-occurring disorders is the term SAMHSA, NIDA, and NIMH use today. The Substance Abuse and Mental Health Services Administration (SAMHSA) uses it to describe a person who has at least one mental disorder and at least one substance use disorder, with each diagnosable on its own rather than one simply being a symptom of the other.

Dual diagnosis is another name for the same thing. SAMHSA's treatment guidance uses "co-occurring disorders" as its main term, and you'll see both on websites and in paperwork.

So if two websites seem to disagree, they're probably using different words for one clinical picture. What matters for care is which specific conditions are present and how severe each one is.

How common co-occurring disorders are

More common than most families expect. The National Institute on Drug Abuse notes that people with substance use disorders often have co-occurring mental disorders, and the reverse is true too. As NIDA notes, people treated for one condition can be screened for the other.

Two conditions, one person. Not two separate problems.

Why the two conditions feed each other

The relationship runs in both directions, and the National Institute of Mental Health points to several ways they connect:

1. Shared risk factors. Genetics, chronic stress, and trauma raise the risk of both mental disorders and substance use disorders.
2. Using substances to cope. Someone with untreated anxiety may drink to get through the evening. It works briefly, then makes the underlying condition worse.
3. Substance use changing the brain. Repeated use can alter brain systems in ways that raise the risk of developing other mental disorders.

Which came first? Often, nobody can say for sure, and treatment doesn't wait for the answer.

Why diagnosis is harder when both are present

Intoxication and withdrawal can look almost exactly like psychiatric symptoms. Alcohol withdrawal, for example, can produce anxiety that's hard to tell apart from an anxiety disorder.

This is why a careful evaluation looks at timing: did the symptoms exist before the substance use, or do they persist for about a month or more after it stops? SAMHSA's TIP 42, following DSM-5, uses this test to separate an independent mental disorder from a substance-induced one. A firm answer can take weeks or months of abstinence.

It's worth the wait, because the answer informs the treatment plan. Picture someone whose untreated bipolar disorder drives their drinking: treat only the alcohol use and relapse is likely. Or someone whose anxiety was withdrawal all along: they may not need long-term psychiatric medication at all.

What integrated treatment looks like

For years, people with co-occurring disorders were told to get sober first, then address their mental health, or the reverse. Two separate systems, two separate teams, and the person caught in between.

The current standard is integrated treatment, which NIMH describes as care that combines mental health and substance use treatment rather than splitting it across providers. In practice, that usually means:

• One coordinated treatment plan that names every condition and how each one affects the others
• Psychiatric care that accounts for substance use when choosing and monitoring medications
• Therapy for both conditions together, using approaches such as cognitive behavioral therapy and motivational interviewing
• The right level of care, which may mean a structured outpatient program several days a week rather than a single weekly appointment
• Support for physical health, sleep, and daily routines, since both conditions take a toll on the body

Medication choices are individual and depend on the specific diagnoses, the substances involved, and the person's history. That decision belongs with a psychiatrist who knows the full picture.

How we treat co-occurring disorders at Amae Health

Co-occurring substance use disorder is one of the conditions our clinics specialize in, alongside the severe mental illness (SMI) diagnoses we treat every day: schizophrenia, bipolar disorder, major depressive disorder, and borderline personality disorder.

Our care model brings a multidisciplinary team under one roof. Psychiatrists manage medication and the overall treatment plan. Therapists provide individual and group therapy. Primary care physicians, dietitians, health coaches, peer mentors, and care coordinators work from the same plan, so nobody has to carry information between offices.

For people who need more structure than weekly visits, we offer a Partial Hospitalization Program (PHP) and an Intensive Outpatient Program (IOP). If you're unsure which fits, our guide to PHP vs. IOP explains the difference.

Frequently asked questions

Is dual diagnosis the same as co-occurring disorders?

Yes. Both terms describe a person who has a mental health condition and a substance use disorder at the same time. "Dual diagnosis" is another name for co-occurring disorders.

Which comes first, the mental illness or the substance use?

It varies. Sometimes a mental health condition comes first and substance use begins as a way to cope. Sometimes substance use comes first and contributes to a mental disorder. Shared risk factors like genetics and trauma can drive both. A good evaluation looks at timing, but treatment can start before the order is clear.

Can both conditions be treated at the same time?

Yes, and federal guidance recommends it. Integrated treatment addresses the mental health condition and the substance use disorder through one coordinated plan instead of sending a person to separate programs in sequence.

What are common examples of co-occurring disorders?

Depression, anxiety, and bipolar disorder are among the mental health conditions NIMH names as often occurring alongside a substance use disorder. Many people also have anxiety and depression together alongside a substance use disorder.

The takeaway

When it comes to dual diagnosis vs co-occurring disorders, the labels differ but the clinical reality is the same: two or more conditions that shape each other and need to be treated together. The term on the paperwork matters far less than whether the care plan addresses all of them at once.

If you or someone you love is living with a mental health condition and substance use, request an intake appointment and a member of our team will talk through what's happening and which level of care fits.

If you're in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline.

People researching lithium vs Lamictal usually want a winner, and the evidence does not crown one. Lithium and Lamictal (lamotrigine) are both used to prevent mood episodes in bipolar disorder, and they differ in ways that matter: which pole of the illness each protects against best, how much monitoring each requires, and what risks each carries. Those differences, not a ranking, are what actually decide which one a psychiatrist reaches for. This comparison walks through how each medication works, what the research shows, their side effects and safety considerations, and the questions that shape the choice, including pregnancy planning and whether the two can be combined.

How Each Medication Works and What It Is Approved For

Lithium is the oldest mood stabilizer in psychiatry and still one of its most effective tools. It is used to treat acute manic episodes and as maintenance treatment, meaning ongoing medication that lowers the risk of future episodes.

Lamotrigine, sold as Lamictal, came to psychiatry from epilepsy treatment. It is an anticonvulsant, and its FDA approval in bipolar disorder covers maintenance treatment of bipolar I disorder, to delay the time to new mood episodes. It is not approved for treating acute mania, which means a person in the middle of a manic episode needs something else. In practice, lamotrigine's role is prevention, and clinicians most often think of it in connection with the depressive side of the illness.

Lithium vs Lamictal: Side-by-Side

What the Research Shows

The cleanest head-to-head data comes from an 18-month placebo-controlled trial in people with bipolar I disorder who had recently been depressed, with 463 patients randomized to lamotrigine, lithium, or placebo (Calabrese et al., Journal of Clinical Psychiatry, 2003). Lamotrigine beat placebo at delaying depressive episodes: at one year, 57% of people on lamotrigine had needed no intervention for depression, compared with 45% on placebo. Lithium beat placebo at delaying manic and hypomanic episodes, with 86% intervention-free for mania at one year versus 72% on placebo.

A 2021 Cochrane review pooling 11 trials and 2,314 participants filled in the comparison between the two drugs (summarized in American Family Physician, 2022). Lamotrigine and lithium had similar rates of depressive recurrence. Lamotrigine was less effective than lithium at reducing manic recurrence at one year. And fewer people on lamotrigine reported side effects than people on lithium over 6 to 12 months, a practical signal about tolerability.

You will often see this compressed into a slogan: Lamictal for depression, lithium for mania. The slogan is directionally useful and too simple. Lamotrigine's depressive-prevention results were similar to lithium's in the Cochrane data, and the absolute differences in the Calabrese trial were modest. Episode history, side effects, and monitoring preferences do more work in the real decision than the slogan suggests.

Monitoring and Safety

Lithium's prescribing information builds monitoring into the treatment: regular serum level checks, because the gap between a helpful and a harmful level is narrow, plus periodic kidney and thyroid testing, since the label identifies both as organs lithium can affect. For many people this becomes an unremarkable part of the routine, a few blood draws a year once stable. It is a real commitment, and a manageable one.

Lamotrigine does not require routine blood level monitoring, which is one of its practical appeals. Its defining safety issue is different: an FDA boxed warning for serious skin rashes, including Stevens-Johnson syndrome. Per the label, serious rash is rare, nearly all cases appear in the first 2 to 8 weeks of treatment, and the slow dose escalation the label requires exists to reduce that risk. This is why lamotrigine cannot be started quickly, and why any new rash during those early weeks should be reported to the prescriber right away. Neither safety profile is a reason for alarm. Both are reasons the medication belongs under a psychiatrist's supervision.

Side Effects Compared

The side effects most commonly reported with lithium in its labeling and the clinical literature are tremor, increased thirst and urination, weight gain, and thyroid effects, usually an underactive thyroid that is itself treatable. Lamotrigine is generally described as weight-neutral in the literature, with headache, dizziness, and nausea its commonly reported side effects, along with the rash risk described above. For someone whose previous medication caused significant weight gain, that difference alone can shape the conversation. For someone whose illness leans heavily manic, lithium's strength against that pole can outweigh its side-effect burden.

Suicide Risk and Lithium: What Is and Is Not Established

Lithium is frequently described as the mood stabilizer that prevents suicide, and the research record deserves more precision than that. A 2013 meta-analysis in The BMJ (Cipriani et al.) reported fewer suicides among people taking lithium than among controls. A 2022 reanalysis in Epidemiology and Psychiatric Sciences (Nabi et al.) reached a different conclusion: restricted to randomized trials, the evidence is inconclusive, because suicide is rare and a handful of events drive the estimates. Researchers are actively debating which analysis handles the data better. Lithium may protect against suicide, but the randomized evidence can't yet confirm it, so the question remains open.

Pregnancy and Planning Ahead

Lithium and lamotrigine carry different considerations in pregnancy, and this is a planning conversation rather than a verdict. For anyone who could become pregnant, the time to discuss medication is before conception, with a psychiatrist who can weigh episode history against the specific risks and benefits of each option, sometimes alongside an obstetrician. Untreated bipolar disorder in pregnancy carries its own serious risks, so the goal of that conversation is a plan that protects both the pregnancy and the person's stability, not a reflexive stop.

Can Lithium and Lamictal Be Used Together?

Yes, and the combination is common in clinical practice. The usual logic pairs lithium's protection against manic episodes with lamotrigine's role on the depressive side. Whether that combination fits any individual person is a psychiatrist's call, made from their episode pattern, their response history, and how they tolerate each medication.

Talking to a Psychiatrist About the Right Fit

The lithium vs lamotrigine decision runs through a short list of personal questions. Which pole of the illness has dominated your history, mania or depression? How do you feel about regular blood tests? Which side-effect profile is more livable for you? Are pregnancy plans on the horizon? A psychiatrist who knows your full history turns those answers into a plan, and adjusts it as your life and your illness change. Medication changes should never be self-directed, including stopping a drug that seems to have done its job.

Bipolar disorder treatment at Amae Health pairs that medication expertise with therapy and whole-person support in one coordinated care model, built for people whose illness has been hard to stabilize. If you are weighing these medications, or your current one is not working, talk with an Amae psychiatrist about what fits your history. Our guide to effective bipolar disorder treatment covers the bigger picture beyond medication.

Frequently Asked Questions

Is lithium or Lamictal better for bipolar depression?

Neither is simply better. Lamotrigine is often used to prevent depressive episodes, and in the 2021 Cochrane review its depressive-recurrence results were similar to lithium's. The right choice depends on a person's episode pattern, side-effect tolerance, and history, judged by their psychiatrist.

Is Lamictal effective for mania?

It is not approved for treating acute mania, and in the Cochrane review it was less effective than lithium at preventing manic recurrence at one year. People whose illness runs manic usually need a different or additional medication.

Do I need blood tests on Lamictal?

Routine blood level monitoring is not typically required for lamotrigine, unlike lithium. A clinician still tracks response and side effects, especially during the first weeks.

Why does Lamictal have to be started so slowly?

Slow dose escalation lowers the risk of serious skin rash, the subject of the medication's FDA boxed warning. Nearly all serious rashes occur in the first 2 to 8 weeks, so any rash in that window should be reported promptly.

Does lithium cause weight gain?

For some people, yes. Weight gain is a recognized lithium side effect, alongside tremor, thirst, and thyroid changes, while lamotrigine is generally considered weight-neutral. Individual experience varies widely.

Can you take lithium and Lamictal together?

Yes, the combination is common in clinical practice, often pairing lithium's anti-manic protection with lamotrigine's depressive-side coverage. It is a decision for you and your psychiatrist, never a self-directed change.

What if I am having thoughts of suicide?

The 988 Suicide and Crisis Lifeline offers free, confidential support by call or text, 24/7. If you are in immediate danger, call 911 or go to the nearest emergency room.

Citations

1. Calabrese JR, Bowden CL, Sachs G, et al. "A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder." Journal of Clinical Psychiatry, 2003;64(9):1013-1024. psychiatrist.com. Tier 1 (peer-reviewed RCT).
2. Hashimoto Y, et al. Cochrane review (2021) on lamotrigine for bipolar maintenance, summarized in American Family Physician, 2022. aafp.org. Tier 1 (Cochrane systematic review).
3. Cipriani A, Hawton K, Stockton S, Geddes JR. "Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis." BMJ, 2013;346:f3646. Tier 1 (peer-reviewed meta-analysis).
4. Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J. "Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials." Epidemiology and Psychiatric Sciences, 2022;31:e65. Tier 1 (peer-reviewed meta-analysis).
5. 988 Suicide and Crisis Lifeline. 988lifeline.org. Tier 2 (FAQ only).

Last updated: November 2026.

ADHD in women vs. men is the same condition. What differs is how visible the symptoms are, especially in childhood, and how quickly people get diagnosed. Boys are around three times more likely to be diagnosed with ADHD in childhood, according to the Duke Center for Girls and Women with ADHD. By adulthood, the same source notes, rates are equal. So the gap is less about who has ADHD and more about who gets noticed, and when.

ADHD in Women vs. Men at a Glance

These are tendencies, not rules. Plenty of girls are hyperactive, and plenty of men mostly struggle with focus. The sections below explain where each row comes from.

The Three ADHD Presentations Apply to Everyone

The National Institute of Mental Health describes ADHD as a neurodevelopmental disorder marked by inattention, hyperactivity, and impulsivity that are frequent, show up across settings, and interfere with daily life. The CDC uses the term "presentations" and names three:

• Predominantly Inattentive Presentation: trouble organizing, finishing tasks, following details, or keeping track of things.
• Predominantly Hyperactive-Impulsive Presentation: fidgeting, talking a lot, trouble waiting, acting before thinking.
• Combined Presentation: symptoms of both are present.

Any of the three can occur in anyone, of any sex. Because symptoms can change over time, the CDC notes, a person's presentation can change too. ADHD symptoms can continue into adulthood but may look different in adults. If attention problems overlap with reading or math difficulties, our guide to learning disabilities vs. ADHD explains how the two differ.

ADHD Symptoms in Women vs. Men

When people compare ADHD symptoms in women vs. men, they're usually comparing tendencies within the same three presentations. Here's how those tendencies often look.

How ADHD Often Shows Up in Boys and Men

In boys, ADHD more often shows up in outward behavior that other people can see. In a 2025 study of adults with ADHD, men were more likely than women to recall leaving their seat as children (45.97% vs 34.96%). Common examples:

• Leaving a seat in class, fidgeting, or seeming always "on the go"
• Blurting out answers and interrupting
• Making quick, impulsive decisions

Because these behaviors disrupt a classroom or a household, adults tend to notice them early.

How ADHD Often Shows Up in Girls and Women

In girls and women, ADHD more often turns inward. Inattention is common: losing the thread of a conversation, misplacing things, drifting off during long tasks.

Some women describe compensating: making lists, redoing work late at night, putting in extra effort. That effort can make symptoms harder for others to see. It also wears people down.

For the full picture of how this looks in daily life, including masking, see our guide to high-functioning ADHD in women.

ADHD in Girls vs. Boys: Why the Diagnosis Gap Starts in Childhood

The difference between ADHD in girls vs. boys starts with who gets referred. Disruptive behavior gets attention fast. A child who is quietly lost in thought doesn't.

The bias has deep roots. In 1902, the pediatrician George Still published some of the earliest clinical descriptions of what we now call ADHD. Of his 20 cases, 15 were boys. For much of the following century, the textbook picture of the condition looked like those boys.

Girls' symptoms still don't fit that picture well. The Duke Center notes that ADHD in girls and women is often missed completely or misinterpreted as other conditions, and that co-occurring anxiety and mood disorders can make it harder to identify. A girl who can't focus may be told she's anxious. A girl who is anxious because she can't keep up may only get treated for the anxiety.

None of this means girls have milder ADHD. It means their ADHD is easier to overlook.

Do Women and Men With ADHD Look More Alike in Adulthood?

Largely, yes. This is the part of the comparison most articles skip.

The Duke Center reports that adult rates of ADHD are equal in men and women, and that women are more likely than men to be first diagnosed as adults. Many of those women went through childhood without anyone naming what was going on.

A 2025 study in Frontiers in Global Women's Health looked at 2,257 adults diagnosed with ADHD at clinics in the Netherlands. The researchers concluded that ADHD shows up in a remarkably similar way in men and women. Where differences existed, they were small. In several adult symptoms, women reported higher rates: 80.38% of women said they lose things, compared with 71.40% of men. Looking back on childhood, men more often recalled classroom hyperactivity, with 45.97% reporting leaving their seat, compared with 34.96% of women.

The study has limits. It included only people who had already been diagnosed, it came from one country, and the authors call it exploratory. Still, it fits the larger pattern. The sharpest differences between ADHD in males vs. females appear in childhood, when outward behavior drives who gets seen. By adulthood, the symptoms themselves look much the same.

Hormones and ADHD Symptoms Across the Lifespan

Hormones come up often in this comparison. The science is early. The Duke Center describes emerging research into how hormone changes, such as those across the menstrual cycle and in menopause, may affect ADHD symptoms and treatment. It also states plainly that more research is needed.

Some women do notice that their focus or mood shifts at certain points in their cycle or around menopause. Keeping track of those patterns gives a clinician who knows your history something concrete to work with. But the research doesn't yet support firm conclusions about why it happens or what to change. Any decision about medication belongs in that clinical conversation, not in an article.

When ADHD Comes With Depression, Anxiety, or Bipolar Disorder

ADHD rarely travels alone. The Duke Center notes that girls and women with ADHD often also have anxiety and mood disorders.

That overlap makes diagnosis harder for everyone. Poor concentration, restlessness, sleep problems, and mood changes can come from ADHD, depression, anxiety, or bipolar disorder. They can also come from more than one at once. Sorting out which is which takes a careful psychiatric evaluation that looks at your full history, not a quick checklist.

This is where we can help. ADHD on its own isn't an Amae specialty. But our psychiatry-led teams work with adults whose ADHD occurs alongside depression, anxiety, or bipolar disorder, where the mood or anxiety symptoms are a large part of what's making life hard. You can read about bipolar disorder treatment at Amae or learn more about our care model.

Conclusion

ADHD in women vs. men is one condition with two common patterns of visibility. Boys are more often noticed early because their symptoms are louder, while girls are more often missed and diagnosed later, sometimes as adults. In adulthood, the symptoms look much more alike. If ADHD is showing up alongside depression, anxiety, or bipolar disorder, you can contact us to talk with our team about whether our care fits what you need.

Frequently Asked Questions

Is ADHD more common in men or women?

It depends on whether you mean diagnosis or occurrence. Boys are around three times more likely than girls to be diagnosed in childhood. In adulthood, rates are equal, according to the Duke Center for Girls and Women with ADHD. Much of the childhood gap reflects who gets noticed, not who has ADHD.

Why is ADHD underdiagnosed in girls?

Girls' symptoms are often less disruptive, so they're less likely to prompt a referral. When symptoms are noticed, they're often missed or misread as other conditions, and co-occurring anxiety or mood disorders can make ADHD harder to spot. Our guide to high-functioning ADHD in women covers how this plays out in adult life.

What are the main differences in ADHD symptoms in women vs. men?

In childhood, boys more often show outward symptoms like leaving their seat, while girls more often show inattention. In adults with ADHD, a 2025 study of 2,257 diagnosed patients found the symptoms remarkably similar between men and women, with only small differences.

Can women be diagnosed with ADHD as adults?

Yes. Women are more likely than men to be first diagnosed with ADHD as adults. An evaluation by a psychiatrist or another qualified clinician usually looks at current symptoms and at how things were in childhood.

Do hormones affect ADHD symptoms in women?

Researchers are beginning to study how hormone changes, such as the menstrual cycle and menopause, may affect ADHD symptoms and treatment. More research is needed before firm conclusions can be drawn.

Can ADHD be mistaken for depression or anxiety?

Yes. Trouble concentrating, restlessness, and low mood can appear in all three conditions, and they often occur together. A thorough psychiatric evaluation helps tell them apart. If you're having thoughts of suicide, call or text 988 to reach the 988 Suicide & Crisis Lifeline.